Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implementation of Human Papillomavirus Immunization in the Developing World
Mark Kane, Beatriz Serrano, Silvia de Sanjosé, et al.
Vaccine (2012) Vol. 30, pp. F192-F200
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Comprehensive Control of Human Papillomavirus Infections and Related Diseases
F. Xavier Bosch, Thomas R. Broker, David Forman, et al.
Vaccine (2013) Vol. 31, pp. I1-I31
Open Access | Times Cited: 403
Human Papillomavirus Vaccine Introduction – The First Five Years
Lauri E. Markowitz, Vivien Tsu, Shelley L. Deeks, et al.
Vaccine (2012) Vol. 30, pp. F139-F148
Closed Access | Times Cited: 324
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
F. Xavier Bosch, Thomas R. Broker, David Forman, et al.
Vaccine (2013) Vol. 31, pp. H1-H31
Open Access | Times Cited: 302
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano, Laia Alemany, Sara Tous, et al.
Infectious Agents and Cancer (2012) Vol. 7, Iss. 1
Open Access | Times Cited: 277
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective
Sarah Finocchario‐Kessler, Catherine Wexler, May Maloba, et al.
BMC Women s Health (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 192
The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control
Freddie Bray, Isabelle Soerjomataram
The World Bank eBooks (2015), pp. 23-44
Closed Access | Times Cited: 190
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects
Jannah Wigle, Ernestina Coast, Deborah Watson‐Jones
Vaccine (2013) Vol. 31, Iss. 37, pp. 3811-3817
Open Access | Times Cited: 169
Vaccine strategies: Optimising outcomes
Karin Hardt, Paolo Bonanni, Susan Codi King, et al.
Vaccine (2016) Vol. 34, Iss. 52, pp. 6691-6699
Open Access | Times Cited: 126
HPV Vaccine: Updates and Highlights
Cristina Mendes de Oliveira, José Humberto Tavares Guerreiro Fregnani, Luisa L. Villa
Acta Cytologica (2019) Vol. 63, Iss. 2, pp. 159-168
Closed Access | Times Cited: 98
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
F. Xavier Bosch, Thomas R. Broker, David Forman, et al.
Vaccine (2013) Vol. 31, pp. F1-F31
Open Access | Times Cited: 90
Infrastructure Requirements for Human Papillomavirus Vaccination and Cervical Cancer Screening in Sub-Saharan Africa
Rengaswamy Sankaranarayanan, Rose Anorlu, Ghislain Sangwa‐Lugoma, et al.
Vaccine (2013) Vol. 31, pp. F47-F52
Closed Access | Times Cited: 83
Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013
J. Ladner, Marie-Hélène Besson, Mariana Rodrigues, et al.
BMC Public Health (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 78
Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014
J. Ladner, Marie-Hélène Besson, Étienne Audureau, et al.
BMC Health Services Research (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: a qualitative study
Judy Yuen‐man Siu, Timothy K. F. Fung, Ho Man Leung
International Journal for Equity in Health (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 46
National decision-making for the introduction of new vaccines: A systematic review, 2010–2020
Morgane Donadel, María S. Panero, Lynnette Ametewee, et al.
Vaccine (2021) Vol. 39, Iss. 14, pp. 1897-1909
Open Access | Times Cited: 36
Parents’ knowledge, beliefs, acceptance and uptake of the HPV vaccine in members of The Association of Southeast Asian Nations (ASEAN): A systematic review of quantitative and qualitative studies
Kurnia Wijayanti, Heike Schütze, Catherine MacPhail, et al.
Vaccine (2021) Vol. 39, Iss. 17, pp. 2335-2343
Closed Access | Times Cited: 35
The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer
Mariano Guardado-Estrada, Eligia Juárez-Torres, Edgar Román‐Bassaure, et al.
PLoS ONE (2014) Vol. 9, Iss. 10, pp. e109406-e109406
Open Access | Times Cited: 47
Successive introduction of four new vaccines in Rwanda: High coverage and rapid scale up of Rwanda's expanded immunization program from 2009 to 2013
Maurice Gatera, Sunil Bhatt, Fidèle Ngabo, et al.
Vaccine (2015) Vol. 34, Iss. 29, pp. 3420-3426
Closed Access | Times Cited: 47
Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries
Margaret Demment, Karen Peters, J. Andrew Dykens, et al.
PLoS ONE (2015) Vol. 10, Iss. 9, pp. e0134618-e0134618
Open Access | Times Cited: 42
Human papillomaviruses-related cancers
Ala‐Eddin Al Moustafa, Rana Al‐Awadhi, Nabiha Missaoui, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 7, pp. 1812-1821
Open Access | Times Cited: 38
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Xiuting Mo, Ruoyan Gai, Lijie Wang, et al.
BMC Infectious Diseases (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 38
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
F. Xavier Bosch, Thomas R. Broker, David Forman, et al.
Vaccine (2013) Vol. 31, pp. G1-G31
Open Access | Times Cited: 38
Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes
Mauricio Hernández‐Ávila, Leticia Torres‐Ibarra, Margaret Stanley, et al.
Human Vaccines & Immunotherapeutics (2015) Vol. 12, Iss. 1, pp. 30-38
Open Access | Times Cited: 34
The influence of knowledge, attitude, and motivational factors on the willingness of mothers for their female children to undergo human papillomavirus vaccination
Sybil Lizanne Bravo
Philippine Journal of Obstetrics and Gynecology (2025) Vol. 49, Iss. 1, pp. 18-42
Closed Access
Sustaining Vaccine Confidence in the 21st Century
Karin Hardt, Ruprecht Schmidt‐Ott, S Glismann, et al.
Vaccines (2013) Vol. 1, Iss. 3, pp. 204-224
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top